Anxiety symptoms across menopausal stages: a systematic review and meta-analysis
Abstract
To compare the odds of reporting anxiety symptoms across the pre, peri and post-menopausal stages. Medline, PsycInfo, Embase and Web of Science were searched until 16th August 2024. Inclusion criteria were (1) a cross-sectional or longitudinal design (2) a female population aged 18+ (3) assessed anxiety across menopause stages using validated measures. Exclusion criteria were (1) intervention studies (2) systematic reviews (3) studies with samples who had co-morbid physical or psychiatric conditions. Study quality was assessed using the Critical Appraisal Skills Programme tool. 21 studies met the inclusion criteria and 15 studies were included in the meta-analysis. Compared to pre-menopause, women in peri-menopause and post-menopause had higher odds of reporting anxiety symptoms (Pre vs. peri: OR = 1.59, 95% CI: 1.26-2.00; pre vs. post: OR = OR = 1.63, 95% CI: 1.19–2.25). Post-menopausal women had lower odds of anxiety symptoms compared to those in peri-menopause (peri vs. post: OR = 0.79, CI: 0.65–0.96). This review suggests that women in peri-menopause and post-menopause report higher levels of anxiety symptoms compared to pre-menopause, with the highest odds observed during peri-menopause. The menopause transition may represent a period associated with increased reporting of anxiety symptoms, but longitudinal research is needed to clarify directionality, underlying mechanisms, and the role of confounding factors.
Related
- Efficacy and safety of non-hormonal pharmacotherapies for depressive and anxiety symptoms during the menopausal transition and postmenopause: a systematic review.
- Menopausal symptoms, sexual function, and psychological well-being in women across the menopausal transition.
- Sleep symptoms, reproductive hormones, and treatment trajectories across the menopausal transition: analyses of two observational cohorts
- Association of Milk and Dairy Intake with Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-Analysis
- Sex-specificities in anxiety and depressive symptoms across the lifespan and their links with multimodal neuroimaging
BibTeX
@article{mehta2026anxiety,
title = {{Anxiety symptoms across menopausal stages: a systematic review and meta-analysis}},
author = {Alisha Mehta and Aimee Spector and Nora Bahhar and Roopal Desai},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-75578-x},
url = {https://www.nature.com/articles/s41598-026-75578-x},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Anxiety symptoms across menopausal stages: a systematic review and meta-analysis
AU - Alisha Mehta
AU - Aimee Spector
AU - Nora Bahhar
AU - Roopal Desai
PY - 2026
DA - 2026/10/22
JO - Scientific Reports
DO - 10.1038/s41598-026-75578-x
UR - https://www.nature.com/articles/s41598-026-75578-x
AB - To compare the odds of reporting anxiety symptoms across the pre, peri and post-menopausal stages. Medline, PsycInfo, Embase and Web of Science were searched until 16th August 2024. Inclusion criteria were (1) a cross-sectional or longitudinal design (2) a female population aged 18+ (3) assessed anxiety across menopause stages using validated measures. Exclusion criteria were (1) intervention studies (2) systematic reviews (3) studies with samples who had co-morbid physical or psychiatric conditions. Study quality was assessed using the Critical Appraisal Skills Programme tool. 21 studies met the inclusion criteria and 15 studies were included in the meta-analysis. Compared to pre-menopause, women in peri-menopause and post-menopause had higher odds of reporting anxiety symptoms (Pre vs. peri: OR = 1.59, 95% CI: 1.26-2.00; pre vs. post: OR = OR = 1.63, 95% CI: 1.19–2.25). Post-menopausal women had lower odds of anxiety symptoms compared to those in peri-menopause (peri vs. post: OR = 0.79, CI: 0.65–0.96). This review suggests that women in peri-menopause and post-menopause report higher levels of anxiety symptoms compared to pre-menopause, with the highest odds observed during peri-menopause. The menopause transition may represent a period associated with increased reporting of anxiety symptoms, but longitudinal research is needed to clarify directionality, underlying mechanisms, and the role of confounding factors.
SN - 2045-2322
ER -